Summary

for people ages 18-75 (full criteria)
at La Jolla, California and other locations
study started
estimated completion

Description

Summary

The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective in treatment of moderate to severe ulcerative colitis.

Official Title

A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL GROUP, DOSE RANGING STUDY OF ORAL PF-06651600 AND PF-06700841 AS INDUCTION AND CHRONIC THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Keywords

Ulcerative ColitisMayo scoreColitisUlcerColitis, UlcerativePF-06700841PF-06651600

Eligibility

You can join if…

Open to people ages 18-75

  • Diagnosis of ulcerative colitis for greater than/equal to 3 months.
  • Moderate to severe active ulcerative colitis
  • Inadequate response to, loss of response to, or intolerance to at least one conventional therapy for UC.

You CAN'T join if...

  • Pregnant or breastfeeding
  • Clinical findings suggestive of Crohn's Disease
  • History of bowel surgery within 6 months

Locations

  • UCSD Investigational Drug Services not yet accepting patients
    La JollaCalifornia92037United States
  • UCSD Perlman Medical Offices not yet accepting patients
    La JollaCalifornia92037United States
  • UCSD Thorntorn Hospital not yet accepting patients
    La JollaCalifornia92037United States
  • UCSD Altman Clinical and Transitional Research Institute not yet accepting patients
    La JollaCalifornia92093United States
  • Medical Associates Research Group accepting new patients
    San DiegoCalifornia92123United States
  • Clinical Application Laboratories, INC. accepting new patients
    San DiegoCalifornia92103United States
  • San Diego Endoscopy Center accepting new patients
    San DiegoCalifornia92103United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Pfizer
Links
To obtain contact information for a study center near you, click here.
To obtain contact information for a study center near you, click here.
To obtain contact information for a study center near you, click here.
ID
NCT02958865
Phase
Phase 2
Study Type
Interventional
Last Updated